← Leaderboards
Satoru Eguchi
Vanderbilt University
$8,928,684
Attributed
$13,243,203
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,243,203 · 7
By mechanism
R01$13,243,203 · 7
Top collaborators
- Tomoki Hashimoto8 shared
- Rosario G Scalia5 shared
- Victor J. Rizzo4 shared
- Patrick Osei-Owusu2 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Douglas Eugene Vaughan$19,799,621
- Dongsheng Han$121,704
Others in their field
Top investigators on “Cardiovascular Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,558,149
- Judith S. Currier · University Of California Los Angeles$143,001,230
- David M Nathan · Massachusetts Institute Of Technology$141,671,512
- John M Lachin · George Washington University$139,991,329
- Judith S Hochman · New York University School Of Medicine$112,514,057
Research focus
Cardiovascular DiseasesIn VivoSignal TransductionMediatingIn VitroEpidermal Growth Factor ReceptorEventAngiotensin IiMolecularPreventVascular RemodelingBlood VesselsLinkMetalloproteasesCellsPhosphorylationHypertensionAffectPathologicOrganExperimental StudyPlayMouse ModelInflammation
Grant awards (31)
Vascular Pyruvate Kinase M2 in Hypertension$694,190
R01 · FY2025 · HL · contact PI
Roles of aging and cellular senescence in the development of intracranial aneurysm rupture$596,813
R01 · FY2025 · AG
Vascular Pyruvate Kinase M2 in Hypertension$15,648
R01 · FY2025 · HL · contact PI
Roles of aging and cellular senescence in the development of intracranial aneurysm rupture$608,992
R01 · FY2024 · AG
Roles of aging and cellular senescence in the development of intracranial aneurysm rupture$608,992
R01 · FY2023 · AG
EGF-ADAM17 axis in the pathophysiology of intracranial aneurysm$439,103
R01 · FY2023 · NS
EGF-ADAM17 axis in the pathophysiology of intracranial aneurysm$439,103
R01 · FY2022 · NS
EGF-ADAM17 axis in the pathophysiology of intracranial aneurysm$435,140
R01 · FY2021 · NS
Inflammatory Responses of The Visceral Adipose Tissue Microcirculation$477,058
R01 · FY2020 · DK
EGF-ADAM17 axis in the pathophysiology of intracranial aneurysm$439,103
R01 · FY2020 · NS
Inflammatory Responses of The Visceral Adipose Tissue Microcirculation$484,374
R01 · FY2019 · DK
EGF-ADAM17 axis in the pathophysiology of intracranial aneurysm$443,371
R01 · FY2019 · NS
Mechanism of Hypertensive Vascular Remodeling and End-Organ Damage$432,973
R01 · FY2019 · HL · contact PI
Inflammatory Responses of The Visceral Adipose Tissue Microcirculation$396,252
R01 · FY2019 · DK
Inflammatory Responses of The Visceral Adipose Tissue Microcirculation$491,478
R01 · FY2018 · DK
Mechanism of Hypertensive Vascular Remodeling and End-Organ Damage$451,982
R01 · FY2018 · HL · contact PI
Vascular signal as a therapeutic target for abdominal aortic aneurysm$390,000
R01 · FY2018 · HL · contact PI
Inflammatory Responses of The Visceral Adipose Tissue Microcirculation$499,421
R01 · FY2017 · DK
Mechanism of Hypertensive Vascular Remodeling and End-Organ Damage$451,982
R01 · FY2017 · HL · contact PI
Vascular signal as a therapeutic target for abdominal aortic aneurysm$390,000
R01 · FY2017 · HL · contact PI
Mechanism of Hypertensive Vascular Remodeling and End-Organ Damage$451,982
R01 · FY2016 · HL · contact PI
Vascular signal as a therapeutic target for abdominal aortic aneurysm$390,000
R01 · FY2016 · HL · contact PI
Vascular signal as a therapeutic target for abdominal aortic aneurysm$390,000
R01 · FY2015 · HL · contact PI
ADAM activation by Angiotensin II$371,250
R01 · FY2012 · HL · contact PI
ADAM activation by Angiotensin II$375,000
R01 · FY2011 · HL · contact PI
ADAM activation by Angiotensin II$375,000
R01 · FY2010 · HL · contact PI
ADAM activation by Angiotensin II$375,000
R01 · FY2009 · HL · contact PI
ErbB Activation via a Metalloprotease by Angiotensin II$321,078
R01 · FY2007 · HL · contact PI
ErbB Activation via a Metalloprotease by Angiotensin II$330,668
R01 · FY2006 · HL · contact PI
ErbB Activation via a Metalloprotease by Angiotensin II$338,625
R01 · FY2005 · HL
ErbB Activation via a Metalloprotease by Angiotensin II$338,625
R01 · FY2004 · HL